| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study
|
Savona, Michael R
|
|
2019
|
6 |
4 |
p. e194-e203
|
article
|
| 2 |
Can apixaban prevent venous thromboembolism better than rivaroxaban?
|
Akbashev, Mikhail
|
|
2019
|
6 |
4 |
p. e180
|
article
|
| 3 |
Can apixaban prevent venous thromboembolism better than rivaroxaban?
|
Coleman, Craig I
|
|
2019
|
6 |
4 |
p. e179
|
article
|
| 4 |
Can apixaban prevent venous thromboembolism better than rivaroxaban? – Authors' reply
|
Dawwas, Ghadeer K
|
|
2019
|
6 |
4 |
p. e181-e182
|
article
|
| 5 |
10-day vs 5-day decitabine: equivalence cannot be concluded
|
Huls, Gerwin
|
|
2019
|
6 |
4 |
p. e177
|
article
|
| 6 |
10-day vs 5-day decitabine: equivalence cannot be concluded – Authors' reply
|
Short, Nicholas J
|
|
2019
|
6 |
4 |
p. e178
|
article
|
| 7 |
Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?
|
de Witte, Theo
|
|
2019
|
6 |
4 |
p. e170-e171
|
article
|
| 8 |
Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial
|
Bolaños-Meade, Javier
|
|
2019
|
6 |
4 |
p. e183-e193
|
article
|
| 9 |
Excellent outcomes for patients with B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses
|
Teachey, David T
|
|
2019
|
6 |
4 |
p. e172-e173
|
article
|
| 10 |
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial
|
Hutchison, Colin A
|
|
2019
|
6 |
4 |
p. e217-e228
|
article
|
| 11 |
Improvements in haploidentical transplantation for sickle cell disease and β-thalassaemia
|
Tisdale, John
|
|
2019
|
6 |
4 |
p. e168-e169
|
article
|
| 12 |
Myeloma cast nephropathy: the dusk of high cutoff haemodialysis
|
Sallée, Marion
|
|
2019
|
6 |
4 |
p. e174-e176
|
article
|
| 13 |
Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial
|
Parker, Catriona
|
|
2019
|
6 |
4 |
p. e204-e216
|
article
|
| 14 |
Sickle-cell anaemia—keeping alive Wethers' legacy
|
The Lancet Haematology,
|
|
2019
|
6 |
4 |
p. e167
|
article
|
Journal description